BMJ1d
Prevention of neurological disease in later life
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
BMJ1d
Hippocampal subfield atrophy of CA1 and subicular structures predict progression to dementia in idiopathic Parkinson’s disease
Background Global hippocampal atrophy is a hallmark of Alzheimer’s dementia and has been similarly reported in Parkinson’s disease dementia (PDD). However, there is limited literature on the ...
BMJ2d
Vasculitic polyradiculopathy in systemic lupus erythematosus
Dr G Midroni, Neurophysiology laboratory, St. Michael’s Hospital, 30 Bond Street, Toronto, Ontario, Canada M5B 1W8. Telephone 00416 864 5193; fax 00416 864 6095. A 22 year old woman with recently ...
BMJ9d
Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II/III randomised controlled study
Objective To evaluate the efficacy and safety of intramuscular ultra-high-dose methylcobalamin in patients with amyotrophic lateral sclerosis (ALS). Methods 373 patients with ALS (El Escorial definite ...
BMJ1d
Deficient saccadic inhibition in Asperger’s disorder and the social-emotional processing disorder
1 Department of Psychiatry and the Athinoula A Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA 2 Department of Psychiatry, ...
BMJ3d
Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis
Background Early fast-acting treatment (EFT) is the aggressive use of fast-acting therapies such as plasmapheresis, intravenous immunoglobulin and/or intravenous high-dose methylprednisolone (IVMP) ...
BMJ8d
Performance validity test failure in clinical populations—a systematic review
Correspondence to Dr Laura McWhirter, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH8 9YL, UK; laura.mcwhirter{at}ed.ac.uk Performance validity tests (PVTs) are widely used ...
BMJ10d
Data-driven evolution of neurosurgical gene therapy delivery in Parkinson’s disease
Loss of nigrostriatal dopaminergic projection neurons is a key pathology in Parkinson’s disease, leading to abnormal function of basal ganglia motor circuits and the accompanying characteristic motor ...
BMJ5d
White-matter diffusion abnormalities in temporal-lobe epilepsy with and without mesial temporal sclerosis
Division of Neurology, Department of Medicine, University of Alberta, Alberta, Canada Dr D W Gross, Division of Neurology, Department of Medicine, 2E3.19 Walter C Mackenzie Health Sciences Centre, ...
BMJ7d
Are men at greater risk for Parkinson’s disease than women?
1 Department of Neurology, University of Virginia School of Medicine, Charlottesville, USA 2 Department of Health Evaluation Sciences, University of Virginia School of Medicine Correspondence to: Dr G ...
BMJ7d
Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study
1 Oxford University, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK 2 Oxford University, Unit of Health-Care Epidemiology, Department of Public Health, Oxford, UK ...